RenovoRx Appoints James Ahlers as Chief Financial Officer
Expands Finance Team with Addition of Ronald B. Kocak, CPA as Vice President and Controller RenovoRx, Inc. a biopharmaceutical company and innovator in targeted cancer therapy is announcing the appointment of James Ahlers as Chief Financial Officer (CFO), effective July 15, 2022, and the addition of Ronald B. Kocak as......